Literature DB >> 2254688

The prevalence of human immunodeficiency virus in patients and their spouses entering a large in vitro fertilization program.

M C Edelstein1, C Kruithoff, L Brothman, L L Veeck, N J Alexander, S J Muasher.   

Abstract

Between September 1987 and August 1989, all patients and their spouses entering our in vitro fertilization (IVF) program were screened for the human immunodeficiency virus (HIV) using the enzyme-linked immunosorbent assay (ELISA). Of 848 patients and 848 spouses tested, all but 4 patients and 1 husband tested negative. Of those who tested positive on repeat testing with ELISA, only one was positive on Western blotting (HIV prevalence, 0.59 per 1000). During this same time period 1187 samples of human cord blood were used to make tissue culture medium for the IVF embryology laboratory. One sample was discarded because of positive HIV on ELISA and Western blotting; two other samples were discarded because of positivity to the hepatitis B surface antigen. While we believe that routine HIV screening of IVF patients and their spouses is indicated, this population is of low risk for HIV positivity. Furthermore, continued screening of human sera used to make tissue culture media for IVF is mandatory.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2254688     DOI: 10.1007/bf01129529

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


  6 in total

1.  Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments.

Authors:  L Resnick; K Veren; S Z Salahuddin; S Tondreau; P D Markham
Journal:  JAMA       Date:  1986-04-11       Impact factor: 56.272

2.  Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor--Colorado.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1986-06-20       Impact factor: 17.586

3.  Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

Authors:  A Ranki; S L Valle; M Krohn; J Antonen; J P Allain; M Leuther; G Franchini; K Krohn
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

4.  Measurement of the false positive rate in a screening program for human immunodeficiency virus infections.

Authors:  D S Burke; J F Brundage; R R Redfield; J J Damato; C A Schable; P Putman; R Visintine; H I Kim
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

5.  Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor.

Authors:  J S McDougal; L S Martin; S P Cort; M Mozen; C M Heldebrant; B L Evatt
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

6.  A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group.

Authors:  S Blanche; C Rouzioux; M L Moscato; F Veber; M J Mayaux; C Jacomet; J Tricoire; A Deville; M Vial; G Firtion
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

  6 in total
  1 in total

1.  Ethical aspects of assisted reproduction in AIDS patients.

Authors:  N Rojansky; J G Schenker
Journal:  J Assist Reprod Genet       Date:  1995-09       Impact factor: 3.412

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.